Kang et al., 1995 - Google Patents
Induction of vitreolysis and vitreous detachment with hyaluronidase and perfluoropropane gas.Kang et al., 1995
View PDF- Document ID
- 4639720828694729477
- Author
- Kang S
- Hyung S
- Choi M
- Lee J
- Publication year
- Publication venue
- Korean Journal of Ophthalmology
External Links
Snippet
To simulate the posterior vitreous detachment (PVD) in the rabbit, 1 IU hyaluronidase and/or 0.2 ml of perfluoropropane gas was intravitreally injected. Ophthalmoscopic, light microscopic examination prepared by cryotechnique, electron microscopic examination, and …
- 208000000318 Vitreous Detachment 0 title abstract description 13
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100463009B1 (en) | Enzymatic Method and Compositions for Treating Intravitreal Hemorrhagic Blood | |
| Kang et al. | Induction of vitreolysis and vitreous detachment with hyaluronidase and perfluoropropane gas. | |
| Nuyts et al. | Histopathologic effects of mitomycin C after trabeculectomy in human glaucomatous eyes with persistent hypotony | |
| US5292509A (en) | Method for the disinsertion of vitreous body by an enzyme which disrupts or degrades chondroitin sulfate proteoglycan | |
| Chang et al. | Experimental vitreous replacement with perfluorotributylamine | |
| Tezel et al. | Posterior vitreous detachment with dispase | |
| Samples et al. | The effect of epinephrine and benzalkonium chloride on culture corneal endothelial and trabecular meshwork cells | |
| Marmor et al. | Osmotically induced retinal detachment in the rabbit and primate. Electron miscoscopy of the pigment epithelium. | |
| Johnson et al. | Tissue plasminogen activator thrombolysis during surgical evacuation of experimental subretinal hemorrhage | |
| Oliveira et al. | Dispase facilitates posterior vitreous detachment during vitrectomy in young pigs | |
| Johnson | The effect of cytochalasin D on outflow facility and the trabecular meshwork of the human eye in perfusion organ culture. | |
| Talamo et al. | The influence of aphakia and vitrectomy on experimental retinal toxicity of aminoglycoside antibiotics | |
| Unal et al. | The efficacy of plasminogen-urokinase combination in inducing posterior vitreous detachment | |
| Sawaguchi et al. | Effects of intracameral injection of chondroitinase ABC in vivo | |
| US5767105A (en) | Ocular solution | |
| Moorhead et al. | Bacterial collagenase: proposed adjunct to vitrectomy with membranectomy | |
| JP2002543143A (en) | Biochemical methods to eliminate corneal scarring, opacity and haze | |
| LE MER et al. | TPA-assisted vitrectomy for proliferative diabetic retinopathy: results of a double-masked, multicenter trial | |
| US20070032427A1 (en) | Methods and compositions for preserving the viability of photoreceptor cells | |
| Tanaka et al. | Pharmacological vitrectomy | |
| US20040081643A1 (en) | Process for inhibiting vascular proliferation in the eye | |
| US6733750B1 (en) | Process and composition for inducing posterior vitreous detachment | |
| US5722428A (en) | Method for producing a posterior vitreous detachment | |
| Fukuchi et al. | Corneal endothelial damage after trabeculectomy with mitomycin C in two patients with glaucoma with cornea guttata | |
| Cillino et al. | Topical flurbiprofen in extracapsular cataract surgery: Effect on pupillary diameter and iris fluorescein leakage |